Intellectual Property

Apex AI is committed to pioneering AI-driven gastrointestinal cancer diagnostics through continuous research and development. Our intellectual property portfolio includes multiple patents and software copyrights, solidifying our leadership in AI-powered medical imaging and predictive diagnostics.

Patents & Intellectual Property Filings

No.	Patent Holder	Country	Status	Patent Number	Title / Description
1	Apex AI	South Korea	Filed	10-2020-0003735	Graph Model-Based AI System for Log Analysis & Batch Scheduling
2	Apex AI	South Korea	Filed	10-2020-0052393	AI-Based Stomach Endoscopy Image Analysis for Cancer Risk Prediction
3	Apex AI	South Korea	Filed	10-2021-0025707	AI-Based Colonoscopy Image Analysis for Colorectal Cancer Risk Prediction
4	Apex AI	South Korea	Filed	10-2021-0025708	AI-Based Gastrointestinal Endoscopy Analysis for Cancer Risk Prediction
5	Apex AI	South Korea	Filed	10-2021-0025709	AI-Based Small Intestine Endoscopy Analysis for Abnormality Detection
6	Apex AI	South Korea	Filed	10-2021-0025710	AI-Based Temporal Medical Image Data Analysis for Disease Onset Prediction
7	Apex AI	South Korea	Filed	10-2021-0026094	Feedback-Based AI Machine Learning Optimization System
8	Apex AI	South Korea	Filed	10-2023-0113554	AI-Based Predictive Model for Disease Onset Using Temporal Medical Data
9	Apex AI	South Korea	Filed	10-2023-0113555	AI-Based Stepwise Learning System for Efficient Machine Learning

---

Software Copyrights & Certifications

Category	Certified By	Certification Number	Description
Software Copyright	Korea Copyright Commission	C-2020-014150	AI Stomach Cancer Prediction Program (AI-powered risk assessment & predictive modeling for gastric cancer)